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Abstract: Twin pregnancies are commonly assessed using singleton growth and birth weight refer-
ence charts. This practice has led to a significant number of twins labelled as small for gestational age
(SGA), causing unnecessary interventions and increased risk of iatrogenic preterm birth. However,
the use of twin-specific charts remains controversial. This study aims to assess whether twin-specific
estimated fetal weight (EFW) and birth weight (BW) charts are more predictive of adverse outcomes
compared to singleton charts. Centiles of EFW and BW were calculated using previously published
singleton and twin charts. Categorical data were compared using Chi-square or McNemar tests.
The study included 1740 twin pregnancies, with the following perinatal adverse outcomes recorded:
perinatal death, preterm birth <34 weeks, hypertensive disorders of pregnancy (HDP) and admis-
sions to the neonatal unit (NNU). Twin-specific charts identified prenatally and postnatally a smaller
proportion of infants as SGA compared to singleton charts. However, twin charts showed a higher
percentage of adverse neonatal outcomes in SGA infants than singleton charts. For example, perinatal
death (SGA 7.2% vs. appropriate for gestational age (AGA) 2%, p < 0.0001), preterm birth <34 weeks
(SGA 42.1% vs. AGA 16.4%, p < 0.0001), HDP (SGA 21.2% vs. AGA 13.5%, p = 0.015) and NNU
admissions (SGA 69% vs. AGA 24%, p < 0.0001), when compared to singleton charts (perinatal death:
SGA 2% vs. AGA 1%, p = 0.029), preterm birth <34 weeks: (SGA 20.6% vs. AGA 17.4%, p = 0.020),
NNU admission: (SGA 34.5% vs. AGA 23.9%, p < 0.000). There was no significant association
between HDP and SGA using the singleton charts (p = 0.696). In SGA infants, according to the twin
charts, the incidence of abnormal umbilical artery Doppler was significantly more common than in
SGA using the singleton chart (27.0% vs. 8.1%, p < 0.001). In conclusion, singleton charts misclassify
a large number of twins as at risk of fetal growth restriction. The evidence suggests that the following
twin-specific charts could reduce unnecessary medical interventions prenatally and postnatally.
Keywords: twin pregnancy; singleton; estimated fetal weight; birth weight; small for gestational age;
fetal growth restriction; chorionicity-specific; reference charts; ultrasound
1. Introduction
Twin gestation is a known risk factor for antenatal complications. However, increased fe-
tal surveillance throughout twin pregnancies is associated with a lower risk of stillbirth [1–3].
An important element of twin surveillance includes monitoring to identify fetal growth
restriction (FGR), as evidence suggests that growth-restricted infants are at increased risk of
adverse perinatal outcomes, including increased mortality and morbidity [4]. As a result, it is
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vital to accurately assess the growth of twins antenatally and postnatally, to identify those
who would benefit from preterm birth, altered surveillance and neonatal interventions.
It is currently a routine practice to assess both the antenatal growth and postnatal
birthweight of twins using singleton estimated fetal weight (EFW) and birth weight (BW)
charts, respectively. However, it has been shown that the use of singleton charts to mon-
itor twin pregnancies is not accurate, as twins show a reduced growth rate in the third
trimester [5]. As a result, a significant proportion of all twins are labelled as small for
gestational age (SGA), leading to an increased risk of intervention and the subsequent risks
associated with iatrogenic preterm birth [5–7]. Furthermore, evidence suggests that the
median birth weight in twins is considerably lower than singletons from around week
30–32, which may be leading to unnecessary interventions neonatally [8–10].
To counter this, several twin-specific reference charts and BW reference charts have
been suggested and created to help identify fetuses at risk of adverse outcomes [8,11–14].
However, their use remains controversial, as it is argued that the lower growth rates in twins
may result from true placental insufficiency compared to singletons [15,16]. These preg-
nancies may be overlooked if twin-specific charts are implemented, potentially leading to
increased morbidity and mortality rates.
Due to these two contrasting opinions, the validation of twin EFW and BW charts
is crucial to understand their clinical impact before their use is routinely implemented.
A previous study has suggested that while both customised and non-customised EFW
singleton charts identify more SGA infants, they classify a similar proportion of stillborn
infants compared to the twin-specific EFW charts. Therefore, introducing the twin charts
can reduce unnecessary medical intervention [7]. Consequently, it would be wise to
perform a similar analysis of twin-specific BW charts and compare more recent singleton
fetal growth and BW charts like those presented by Nicolaides et al. [17].
This study’s main aim was to assess if chorionicity-specific twin growth and birth
weight reference charts can better identify high-risk pregnancies compared to previously
published EFW and BW charts—evaluating their ability to predict adverse fetal and neona-
tal outcomes, including perinatal death, preterm birth (PTB), hypertensive disorders of
pregnancy (HDP) and admission to the neonatal unit (NNU).
2. Materials and Methods
2.1. Study Population
A retrospective cohort study of prospectively collected data was performed. The in-
clusion criteria were unselected twin pregnancies at St George’s Hospital, London, UK,
between January 2000 and May 2020. Pregnancies were identified by searching the elec-
tronic maternity records (ViewPoint version 5.6.26.148, ViewPoint Bildverarbeitung GMBH,
Wessling, Germany) and pregnancy outcomes were established from the maternity database
and neonatal records. Exclusion criteria included significant fetal structural anomalies or
aneuploidy, intrauterine death (IUD) of one twin before 24 weeks’ gestation, miscarriage
and missing gestational age at delivery.
2.2. Study Variables and Outcomes
Data on maternal age in years, body mass index (BMI) in kg/m2, reported ethnicity,
mode of conception and smoking were collected. The last prenatal ultrasound examination
reporting EFW and fetal Doppler assessment were used in the analysis. HDP included
gestational hypertension and preeclampsia defined by the International Society for the
Study of Hypertension in Pregnancy (ISSHP) guidelines [18]. Chorionicity was determined
based on the presence or absence of the lambda sign at the intertwin membrane–placenta
junction, as well as the intertwin membrane thickness at the site of its insertion in the
chorion at 11–14 weeks, or the number of placentas and the fetal gender after 14 weeks’
gestation [19–21]. Gestational age (GA) was determined according to the crown-rump
length (in the first trimester) or head circumference (after 14 weeks’ gestation) of the
larger fetus in cases of spontaneous conception and according to the embryonic age from
J. Clin. Med. 2021, 10, 643 3 of 9
fertilisation if in-vitro fertilisation had taken place [19,22,23]. The centiles of EFW were
calculated adopting the singleton chart by Nicolaides et al. [17] and the twin charts by
Stirrup et al. [9]. The BW centiles were assessed using the singleton standard reported by
Nicolaides et al. [17] and twin chorionicity-specific reference standards reported by Briffa
et al. [24]. Fetuses with EFW less than 10th centile and newborns with BW less than 10th
centile were considered SGA. The outcomes of SGA fetuses, according to twin charts, were
compared with those of SGA fetuses according to singleton charts. The same comparison
was performed among SGA neonates defined by twin or singleton standards. Moreover,
a sub-group analysis was performed in SGA twins identified by both charts, SGA twins
identified only by singleton charts and in AGA infants detected by both charts before birth
(using EFW) and after birth (using BW).
The study outcomes were:
• Perinatal death, which includes stillbirth (IUD after 24 completed weeks of pregnancy)
and early neonatal death (death of a newborn within seven days after birth),
• PTB before 34 weeks’ gestation,
• HDP,
• Admission to NNU.
We also evaluated fetal Doppler abnormalities in the twin pregnancies with SGA
fetuses defined by twin vs. those by singleton charts. The pulsatility index (PI) of the
umbilical artery (UA) and middle cerebral artery (MCA) and the cerebro-placental ratio
(CPR), which is the ratio between MCA-PI and UA-PI, were recorded. Abnormal UA
Doppler was defined when the PI was above the 95th centile [25], absent (AEDF) or
reversed EDF (REDF).
2.3. Statistical Analysis
Categorical data were presented as number (%) and compared using Fisher’s exact
test or Chi-square test. The D’Agostino and Pearson Omnibus test was used to assess
the normality of the data. Continuous data were presented as median (interquartile
range, IQR).
According to twin and singleton charts, the proportions of SGA fetuses and neonates
were determined and compared using Chi-squared and McNemar tests. A logistic regres-
sion model was performed in univariate analysis to study the association between adverse
outcomes and growth abnormalities in twins identified by using different standards during
pregnancy and at birth. Odds ratio (OR) and 95% confidence intervals (95% CI) were
calculated. p-values below 0.05 were considered statistically significant. The statistical
analysis was performed using SPSS version 26.0 (SPSS, Statistical Package for the Social
Sciences, IBM, Armonk, NY, USA) statistical software.
3. Results
3.1. Study Population
The study included 1740 twin pregnancies: dichorionic (77.5%) and monochorionic
(22.5%). The median maternal age was 34 years, and median BMI was 24.4 kg/m2. Data on
demographics, pregnancy characteristics and outcomes are shown in Table 1. The median
gestational age at delivery was 36.7 weeks and the incidence of PTB before 34 weeks’
gestation was 20.3%. The incidence of HDP was 14%, while that of perinatal death was
1.5%. The incidence of NNU admission was 29.1%.
Using the twin chart, 278 fetuses (8.3%) were identified as SGA, while the singleton
chart identified 1172 SGA fetuses (34.8%) (p < 0.001). Number of neonates with a BW less
than 10th centile were 249 (7.3%) using the twin chart and 1324 (38.4%) using the singleton
chart (p < 0.001).
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Table 1. Baseline demographics and pregnancy characteristics of the study cohort.
Twin Pregnancies
(n = 1740)
Maternal age in years, median (IQR) 34 (30–37)
Maternal body mass index in kg/m2, median (IQR) 24.4 (21.8–27.9)
Nulliparous, n (%) 975 (56)











Smokers, n (%) 89 (5.2)
Assisted conception, n (%) 477 (27.6)
Pre-existing hypertension, n (%) 59 (3.4)
Gestational age at delivery in weeks, median (IQR) 36.7 (34.6–37.4)
Hypertensive disorders of pregnancy, n (%) 243 (14)
Preterm birth before 34 weeks, n (%) 354 (20.3)




 Stillbirth, n (%)
 Early neonatal death, n (%)
31 (0.9)
22 (0.6)
Birthweight in grams, median (IQR) 2301 (1902–2595)
Admission to the neonatal unit, n (%) 1003 (29.1)
3.2. EFW Centile According to Twin References versus Singleton References
EFW less than 10th centile using a twin chart was significantly associated with the
risk of perinatal death (7.2% vs. 0.8%, p < 0.0001, OR 9.14, 95% CI 5.0–16.6, p < 0.0001).
Similarly, the risk of PTB prior to 34 weeks’ gestation was significantly higher than in
fetuses classified as AGA (42.1% vs. 16.4%, p < 0.0001, OR 3.7, 95% CI 2.9–4.8, p < 0.0001).
The incidence of HDP was also significantly higher in SGA than AGA fetuses (21.2% vs.
13.5%, p = 0.015, OR 1.7, 95% CI 1.1–2.7, p = 0.016). The risk of NNU admission was also
significantly higher in SGA than in AGA fetuses (69% vs. 24%, p < 0.0001, OR 7.1, 95% CI
5.4–9.3, p < 0.0001) (Tables 2 and 3).
EFW less than 10th centile using a singleton chart was significantly associated with
the risk of adverse outcomes (perinatal deaths: 2% vs. 1%, p = 0.029, OR 1.9, 95% CI 1.1–3.4,
p = 0.032; PTB prior to 34 weeks: 20.6% vs. 17.4%, p = 0.020, OR 1.2, 95% CI 1.0–1.5, p = 0.020;
NNU admission: 34.5% vs. 23.9%, p < 0.0001, OR 1.7, 95% CI 1.4–2.0, p < 0.0001). The
strength of association was lower than when using the twin chart. There was no significant
association between HDP and SGA using the singleton charts (p = 0.696) (Tables 2 and 3).
When each adverse perinatal outcome in SGA babies was compared using the different
charts, SGA babies defined by the twin references were more frequently associated with
perinatal death (7.2% vs. 2%, p < 0.0001), PTB before 34 weeks’ gestation (42.1% vs. 20.6%,
p < 0.0001) and NNU admission (69% vs. 34.5%, p < 0.0001).
Figure 1 illustrates the frequency of adverse fetal outcomes in SGA twins detected by
both EFW charts, in SGA twins identified by only singleton charts and AGA according to
both EFW charts. The proportions of perinatal death, PTB and NNU were similar among
SGA determined by only singleton charts and AGA according to both singleton and twin
EFW charts.
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Table 2. Adverse perinatal outcomes in small for gestational age (SGA) fetuses according to twin vs. singleton chart.
Adverse
Outcomes
EFW-Twin Chart EFW-Singleton Chart BW-Twin Chart BW-Singleton Chart







































































* The results of Chi-square test are presented.
Table 3. The association between small for gestational age (SGA) and adverse perinatal outcomes according to whether
SGA was defined using the twin vs. singleton chart.
Adverse Outcomes
Estimated Fetal Weight < 10th Centile
Twin Chart Singleton Chart
OR 95% CI p Value OR 95% CI p Value
Perinatal death 9.14 5.0–16.6 <0.0001 1.9 1.1–3.4 0.032
Preterm birth prior to 34 weeks 3.7 2.9–4.8 <0.0001 1.2 1.0–1.5 0.020
Neonatal unit admission 7.1 5.4–9.3 <0.0001 1.7 1.4–2.0 <0.0001
Hypertensive disorders of pregnancy 1.7 1.1–2.7 0.016 1.1 0.8–1.4 0.696
Birth Weight < 10th Centile
Twin Chart Singleton Chart
OR 95% CI p Value OR 95% CI p Value
Perinatal death 8.0 3.3–19.5 <0.0001 1.6 0.7–3.7 0.268
Preterm birth prior to 34 weeks 2.7 2.0–3.5 <0.0001 0.9 0.7–1.0 0.067
Neonatal unit admission 5.6 4.3–7.4 <0.0001 1.1 1.0–1.3 0.095
Hypertensive disorders of pregnancy 2.0 1.2–3.2 0.006 1.2 0.9–1.5 0.274
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Figure 1. Adverse perinatal outcomes in small for gestational age (SGA) fetuses according to singleton and twin charts,
SGA identified only by singleton chart and non-SGA (AGA) fetuses according to singleton and twin charts using estimated
fetal weight.
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3.3. The Comparison of Doppler Assessment in Fetuses with EFW Less than 10th Centile
According to Twin vs. Singleton Chart
Doppler assessments were available for 1132 out of 1172 fetuses defined as SGA using
the singleton chart and 267 out 278 SGA using the twin chart. The median (IQR) UA-PI
was 1.13 (1.00–1.46) in SGA fetuses defined by the twin chart and 1.01 (0.88–1.15) in those
defined by singleton chart, while the median (IQR) CPR was 1.25 (0.88–1.75) in the former
group and 1.62 (1.86–1.41) in the latter group. According to the twin charts, in fetuses
with EFW < 10th centile, the incidence of abnormal UA Doppler, including UA-PI above
the 95th centile AEDF or REDF, was significantly more common than in SGA using the
singleton chart (27.0% vs. 8.1%, p < 0.001).
3.4. BW Centile According to Twin vs. Singleton Chart
Compared to neonates with a BW more than 10th centile, SGA neonates defined by the
twin chart were significantly more likely to experience perinatal death (3.2% vs. 0.4%, OR
8.0, 95% CI 3.3–19.5, p < 0.0001), PTB prior to 34 weeks (36.9% vs. 18.1%, OR 2.7, 95% CI 2.0–
3.5, p < 0.0001), NNU admission (66.3% vs. 25.3%, OR 5.6, 95% CI 4.3–7.4, p < 0.0001) and
HDP (13.5% vs. 23.5%, OR 2.0, 95% 1.2–3.2, p = 0.005). Conversely, no significant differences
were found when the singleton chart was used to define SGA newborns (Tables 2 and 3).
Figure 2 illustrates the frequency of adverse outcomes in SGA twins detected by
both BW charts, in SGA twins identified by only singleton charts and AGA according to
both charts. The proportions of perinatal death, PTB and NNU were similar among SGA
identified by only singleton charts and AGA according to both singleton and twin charts.
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Figure 2. Adverse perinatal outcomes in small for gestational age (SGA) fetuses according to singleton and twin charts,
SGA identified only by singleton chart and non-SGA (AGA) fetuses according to singleton and twin charts using birth
weight.
4. Discussion
4.1. Summary of Main Findings
Twin-specific charts identified prenatally and postnatally a smaller proportion of
fetuses or neonates as SGA than singleton EFW and BW charts. However, of those detected
as SGA using twin-specific references, the likelihood of those infants developing adverse
neonatal outcomes was significantly hig er than those labelled as SGA on the singleton
reference chart alone. Finally, abnormal fetal Doppler was more common in the SGA
defined using the twin than the singleton charts.
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4.2. Interpretation of Study Findings and Comparison with Published Literature
Using customised growth charts according to pregnancy-specific variables has been
a controversial subject [26]. However, the evidence suggests that their use can improve
our ability to identify fetuses at risk of adverse outcomes. Adjusting for twin-specific vari-
ables, for example, chorionicity should, in theory, improve the ‘one-size-fits-all’ approach
currently offered by the use of singleton charts [7]. Recent studies have also proven that
adjusted EFW reference charts for twins reduce the number of twins labelled as SGA and
still identify a similar proportion of stillbirth cases [7]. Furthermore, published studies have
highlighted that twin-specific birthweight charts were more strongly associated with HDP
and PTB than the singleton charts [27–29]. Our results reveal a similar trend, suggesting
that SGA defined using twin-specific charts, both EFW and BW, had a stronger association
between those labelled as SGA and those at risk of adverse outcomes. The fact that the
finding of an abnormal fetal Doppler was more common in the SGA fetuses defined using
twin charts than those using singleton charts suggests the use of twin charts to identify the
fetuses suffering from growth restriction, and hence, at risk of adverse perinatal outcomes.
We previously reported that the combination of discordance in fetal size and Doppler
waveform can predict the risk of perinatal loss in twin pregnancies [25].
4.3. Clinical and Research Implications
Twin pregnancies are monitored frequently due to their high risk of antenatal and
perinatal complications [19,30,31]. However, current methods to assess twin pregnancies
using singleton charts are inadequate. The literature suggests that the growth trajectory
of twin pregnancies from 30 weeks onwards is reduced compared to singletons. As a
result, a significant proportion of twin pregnancies are classified as SGA [5]. Therefore, as
previously described, the rationale behind the development of twin-specific charts is to
account for this difference in growth rates and reduce the number of twins identified as SGA,
reducing unnecessary interventions, in particular, iatrogenic prematurity, NNU admission
and long-term risk of prematurity-related disability [7].
Our study suggests that using twin-specific EFW and BW charts significantly reduces
the proportion of twins classified as SGA. Moreover, these twin-specific charts show a
significant increase in the proportion of SGA infants who experience an adverse outcome,
thereby suggesting that the twin charts are more specific for identifying these high-risk
pregnancies. The benefit of using twin-specific reference charts prenatally is their ability to
reduce the proportion of twins identified as SGA, helping to minimise the risk associated
with preterm iatrogenic birth and the developmental complications associated with it.
In addition to this, our study found that twin-specific BW charts are identifying SGA twins
who are associated with a greater risk of adverse outcomes. These BW charts will allow
clinicians to take a more specific approach to smaller infants, potentially helping to dictate
neonatal management of those infants who are genuinely growth restricted, reducing the
burden of NNU admissions and reducing the cost of care.
Our study provides initial evidence that supports the safety of twin-specific growth
and birth weight charts. However, it would be prudent to recommend prospective and
extensive multi-centre studies.
4.4. Strength and Limitations
Our study’s strengths include the use of a large and diverse cohort of twin pregnancies
from a tertiary care centre in London. The use of modern growth charts, which were not
in active clinical use in our population, will help reduce the risk of intervention bias.
The singleton charts opted for use in this study were recent and derived from a cohort size
of 95,579 pregnancies, all of which used EFW to derive their BW charts. Additionally, the
singleton charts were from a population followed up at a tertiary care centre in London
and a population similar to our cohort. We built on the previous work of Kalafat et al. [7]
to include a comparison of the most recent twin and singleton reference charts.
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Furthermore, we examined the Doppler assessment, a well-defined marker of fetal
growth restriction, in our cohort. However, it should be noted this was a retrospective
analysis of routinely collected data and that the number of perinatal deaths in our cohort
was small. Therefore the analysis for the detection of perinatal death could be underpow-
ered. Finally, the twin BW charts used were developed from some pregnancies in this
cohort, which may lead to an overestimation of the twin BW chart’s performance. However,
as these BW charts were not in routine clinical use, it is unlikely to represent an intervention
bias risk.
We have not assessed all potential confounding factors, for example, gestational and
pregestational diabetes due to missing data. However, we expect this number to be small
in this population, reducing the risk of a confounding bias. Finally, this data’s generaliz-
ability should be cautioned as the results found are only specific to the population cohort
assessed, therefore further prospective studies are recommended before implementation is
considered.
5. Conclusions
Compared to the twin-specific growth and BW charts, singleton charts classified more
fetuses as SGA prenatally and more neonates as SGA postnatally. However, the twin-
specific charts used in the study identified a higher proportion of SGA fetuses who had
adverse outcomes and more fetuses with growth restriction as indicated by abnormal fetal
Doppler assessment. This evidence suggests that the twin-specific charts can safely reduce
unnecessary medical interventions prenatally and postnatally.
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